Inoue K - Search Results

1

Overall survival in Japanese patients with ER+/HER2- advanced breast cancer treated with first-line palbociclib plus letrozole.

Takahashi M, Osako T, Yasojima H, Inoue K, Kawashima M, Maeda H, Ichikawa A, Muramatsu Y, Masuda N. Takahashi M, et al. Among authors: inoue k. Breast Cancer. 2024 Jan;31(1):53-62. doi: 10.1007/s12282-023-01511-z. Epub 2023 Oct 26. Breast Cancer. 2024. PMID: 37882974 Free PMC article.

2

Metastatic breast cancer of HER2 scored 2+ by IHC and HER2 gene amplification assayed by FISH has a good response to single agent therapy with trastuzumab: a case report.

Takahashi M, Inoue K, Goto R, Tamura M, Taguchi K, Takahashi H, Suzuki H, Katsushige K, Ogita M. Takahashi M, et al. Among authors: inoue k. Breast Cancer. 2003;10(2):170-4. doi: 10.1007/BF02967645. Breast Cancer. 2003. PMID: 12736573

3

Combination docetaxel and trastuzumab treatment for patients with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study.

Sato N, Sano M, Tabei T, Asaga T, Ando J, Fujii H, Yamamoto N, Kurosumi M, Inoue K, Kimura M. Sato N, et al. Among authors: inoue k. Breast Cancer. 2006;13(2):166-71. doi: 10.2325/jbcs.13.166. Breast Cancer. 2006. PMID: 16755112 Free article. Clinical Trial.

4

Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.

Takei H, Suemasu K, Kurosumi M, Horii Y, Yoshida T, Ninomiya J, Yoshida M, Hagiwara Y, Kamimura M, Hayashi Y, Inoue K, Tabei T. Takei H, et al. Among authors: inoue k. Breast Cancer. 2007;14(1):16-24. doi: 10.2325/jbcs.14.16. Breast Cancer. 2007. PMID: 17244989 Free article.

5

Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective.

Takei H, Kurosumi M, Yoshida T, Ninomiya J, Hagiwara Y, Kamimura M, Hayashi Y, Tozuka K, Suemasu K, Inoue K, Tabei T. Takei H, et al. Among authors: inoue k. Breast Cancer. 2007;14(4):362-70. doi: 10.2325/jbcs.14.362. Breast Cancer. 2007. PMID: 17986801 Free article. Review.

6

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group.

Inoue K, Nakagami K, Mizutani M, Hozumi Y, Fujiwara Y, Masuda N, Tsukamoto F, Saito M, Miura S, Eguchi K, Shinkai T, Ando M, Watanabe T, Masuda N, Ohashi Y, Sano M, Noguchi S. Inoue K, et al. Breast Cancer Res Treat. 2010 Jan;119(1):127-36. doi: 10.1007/s10549-009-0498-7. Epub 2009 Aug 19. Breast Cancer Res Treat. 2010. PMID: 19690954 Clinical Trial.

7

Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?

Takei H, Kurosumi M, Yoshida T, Hayashi Y, Higuchi T, Uchida S, Ninomiya J, Oba H, Inoue K, Nagai S, Tabei T. Takei H, et al. Among authors: inoue k. Breast Cancer. 2011 Apr;18(2):85-91. doi: 10.1007/s12282-010-0239-0. Epub 2010 Nov 23. Breast Cancer. 2011. PMID: 21104350 Review.

8

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.

Tokudome N, Ito Y, Takahashi S, Kobayashi K, Taira S, Tsutsumi C, Oto M, Oba M, Inoue K, Kuwayama A, Masumura K, Nakayama Y, Watanabe C, Hatake K. Tokudome N, et al. Among authors: inoue k. Breast Cancer. 2011 Jul;18(3):195-202. doi: 10.1007/s12282-011-0259-4. Epub 2011 Apr 5. Breast Cancer. 2011. PMID: 21465230 Clinical Trial.

9

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.

Aogi K, Sakai H, Yoshizawa H, Masuda N, Katakami N, Yanagita Y, Inoue K, Kuranami M, Mizutani M, Masuda N. Aogi K, et al. Among authors: inoue k. Support Care Cancer. 2012 Jul;20(7):1507-14. doi: 10.1007/s00520-011-1239-0. Epub 2011 Aug 2. Support Care Cancer. 2012. PMID: 21808994 Clinical Trial.

10

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.

Toi M, Saeki T, Iwata H, Inoue K, Tokuda Y, Sato Y, Ito Y, Aogi K, Takatsuka Y, Arioka H. Toi M, et al. Among authors: inoue k. Breast Cancer. 2014 Jan;21(1):20-7. doi: 10.1007/s12282-012-0344-3. Epub 2012 Mar 2. Breast Cancer. 2014. PMID: 22382811 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,860 results

Search Page